These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21745223)

  • 1. Fluoroscopic left ventricular lead position and the long-term clinical outcome of cardiac resynchronization therapy.
    Foley PW; Chalil S; Ratib K; Smith R; Prinzen F; Auricchio A; Leyva F
    Pacing Clin Electrophysiol; 2011 Jul; 34(7):785-97. PubMed ID: 21745223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sites of left and right ventricular lead implantation and response to cardiac resynchronization therapy observations from the REVERSE trial.
    Thébault C; Donal E; Meunier C; Gervais R; Gerritse B; Gold MR; Abraham WT; Linde C; Daubert JC;
    Eur Heart J; 2012 Nov; 33(21):2662-71. PubMed ID: 22285578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality and morbidity in cardiac resynchronization patients: impact of lead position, paced left ventricular QRS morphology and other characteristics on long-term outcome.
    Jastrzebski M; Wilinski J; Fijorek K; Sondej T; Czarnecka D
    Europace; 2013 Feb; 15(2):258-65. PubMed ID: 23047489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invasive acute hemodynamic response to guide left ventricular lead implantation predicts chronic remodeling in patients undergoing cardiac resynchronization therapy.
    Duckett SG; Ginks M; Shetty AK; Bostock J; Gill JS; Hamid S; Kapetanakis S; Cunliffe E; Razavi R; Carr-White G; Rinaldi CA
    J Am Coll Cardiol; 2011 Sep; 58(11):1128-36. PubMed ID: 21884950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of right ventricular lead location on response to cardiac resynchronization therapy in patients with end-stage heart failure.
    Haghjoo M; Bonakdar HR; Jorat MV; Fazelifar AF; Alizadeh A; Ojaghi-Haghjghi Z; Esmaielzadeh M; Sadr-Ameli MA
    Europace; 2009 Mar; 11(3):356-63. PubMed ID: 19136489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Outcomes of Cardiac Resynchronization Therapy Using Apical Versus Nonapical Left Ventricular Pacing.
    Leyva F; Zegard A; Taylor RJ; Foley PWX; Umar F; Patel K; Panting J; van Dam P; Prinzen FW; Marshall H; Qiu T
    J Am Heart Assoc; 2018 Aug; 7(16):e008508. PubMed ID: 30369313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the efficacy of two surgical alternatives for cardiac resynchronization therapy: trans-apical versus epicardial left ventricular pacing.
    Mihalcz A; Kassai I; Kardos A; Foldesi C; Theuns D; Szili-Torok T
    Pacing Clin Electrophysiol; 2012 Feb; 35(2):124-30. PubMed ID: 22017475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic benefit of optimum left ventricular lead position in cardiac resynchronization therapy: follow-up of the TARGET Study Cohort (Targeted Left Ventricular Lead Placement to guide Cardiac Resynchronization Therapy).
    Kydd AC; Khan FZ; Watson WD; Pugh PJ; Virdee MS; Dutka DP
    JACC Heart Fail; 2014 Jun; 2(3):205-12. PubMed ID: 24952685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resynchronization: what if the left ventricular lead cannot reach the lateral or posterolateral wall?
    D'Ivernois C; Lesage J; Blanc P
    Pacing Clin Electrophysiol; 2008 Aug; 31(8):1041-5. PubMed ID: 18684261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac resynchronization therapy in patients undergoing atrioventricular junction ablation for permanent atrial fibrillation: a randomized trial.
    Brignole M; Botto G; Mont L; Iacopino S; De Marchi G; Oddone D; Luzi M; Tolosana JM; Navazio A; Menozzi C
    Eur Heart J; 2011 Oct; 32(19):2420-9. PubMed ID: 21606084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive factors of difficult implantation procedure in cardiac resynchronization therapy.
    Bisch L; Da Costa A; Dauphinot V; Romeyer-Bouchard C; Khris L; M'baye A; Isaaz K
    Europace; 2010 Aug; 12(8):1141-8. PubMed ID: 20573673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the Attain Select II catheter delivery system to improve.
    Zhou XH; Tang BP; Li JX; Zhang Y; Zhang JH; Li YD
    Chin Med J (Engl); 2011 Apr; 124(8):1209-12. PubMed ID: 21542998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel approach for endocardial resynchronization therapy: initial experience with transapical implantation of the left ventricular lead.
    Kassai I; Mihalcz A; Foldesi C; Kardos A; Szili-Torok T
    Heart Surg Forum; 2009 Jun; 12(3):E137-40. PubMed ID: 19546062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left and right ventricular lead positions are imprecisely determined by fluoroscopy in cardiac resynchronization therapy: a comparison with cardiac computed tomography.
    Sommer A; Kronborg MB; Nørgaard BL; Gerdes C; Mortensen PT; Nielsen JC
    Europace; 2014 Sep; 16(9):1334-41. PubMed ID: 24687965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similar long-term benefits conferred by apical versus mid-septal implantation of the right ventricular lead in recipients of cardiac resynchronization therapy systems.
    Bulava A; Lukl J
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S32-7. PubMed ID: 19250108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular lead position for cardiac resynchronization: a comprehensive cinegraphic, echocardiographic, clinical, and survival analysis.
    Dong YX; Powell BD; Asirvatham SJ; Friedman PA; Rea RF; Webster TL; Brooke KL; Hodge DO; Wiste HJ; Yang YZ; Hayes DL; Cha YM
    Europace; 2012 Aug; 14(8):1139-47. PubMed ID: 22467754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between improvement in left ventricular dyssynchrony and contractile function and clinical outcome with cardiac resynchronization therapy: the MADIT-CRT trial.
    Pouleur AC; Knappe D; Shah AM; Uno H; Bourgoun M; Foster E; McNitt S; Hall WJ; Zareba W; Goldenberg I; Moss AJ; Pfeffer MA; Solomon SD;
    Eur Heart J; 2011 Jul; 32(14):1720-9. PubMed ID: 21609974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular lead position, mechanical activation, and myocardial scar in relation to left ventricular reverse remodeling and clinical outcomes after cardiac resynchronization therapy: A feature-tracking and contrast-enhanced cardiovascular magnetic resonance study.
    Taylor RJ; Umar F; Panting JR; Stegemann B; Leyva F
    Heart Rhythm; 2016 Feb; 13(2):481-9. PubMed ID: 26498258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morbidity and mortality in heart failure patients treated with cardiac resynchronization therapy: influence of pre-implantation characteristics on long-term outcome.
    van Bommel RJ; Borleffs CJ; Ypenburg C; Marsan NA; Delgado V; Bertini M; van der Wall EE; Schalij MJ; Bax JJ
    Eur Heart J; 2010 Nov; 31(22):2783-90. PubMed ID: 20693544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between implantable cardioverter-defibrillator therapy and different lead positions in patients with cardiac resynchronization therapy.
    Kronborg MB; Johansen JB; Haarbo J; Riahi S; Philbert BT; Jørgensen OD; Nielsen JC
    Europace; 2018 Sep; 20(9):e133-e139. PubMed ID: 29036292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.